Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 4Waldenstrom Macroglobulinemia 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lymphoma 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

fludarabine phosphate 4Cyclophosphamide 4Rituximab 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Filgrastim 3Etoposide 3Cyclosporine 3venetoclax 2Whole-Body Irradiation 2Ifosfamide 2Cord Blood Stem Cell Transplantation 2Carboplatin 2veltuzumab 1pirtobrutinib 1pevonedistat 1ocaratuzumab 1iratumumab 1fludarabine 1etoposide phosphate 1aldesleukin 1Vincristine 1Tacrolimus 1Sirolimus 1Psychiatric Rehabilitation 1Prednisone 1Microarray Analysis 1Methotrexate 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Dendritic Cell Sarcoma, Interdigitating × pirtobrutinib × Clear all
NCT03740529 2026-01-27

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

Eli Lilly and Company

Phase 1/2 Completed
803 enrolled 2 FDA
LymphoidOther hematologic neoplasmSarcoma

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡